U
Medite Cancer Diagnostics, Inc. MDIT
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2018 06/30/2018 03/31/2018 12/31/2017 09/30/2017
Revenue 41.99% 78.15% -20.41% 0.36% -27.92%
Total Other Revenue -- -- -- -- --
Total Revenue 41.99% 78.15% -20.41% 0.36% -27.92%
Cost of Revenue -29.76% -1.06% -3.39% 91.34% -1.42%
Gross Profit 298.10% 2,063.27% -50.74% -313.21% -63.21%
SG&A Expenses 8.97% -37.95% 17.52% 109.53% 45.12%
Depreciation & Amortization -43.64% 25.93% 44.90% 33.33% 107.55%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -19.66% -18.88% -0.08% 70.98% 21.30%
Operating Income 93.27% 98.21% -66.67% -212.08% -556.74%
Income Before Tax 54.21% 65.52% -46.81% -170.57% -412.78%
Income Tax Expenses -- 0.00% -- -312.61% --
Earnings from Continuing Operations 54.21% 65.35% -46.81% -154.21% -424.51%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 54.21% 65.35% -46.81% -154.21% -424.51%
EBIT 93.27% 98.21% -66.67% -212.08% -556.74%
EBITDA 97.47% 102.65% -68.69% -223.77% -703.70%
EPS Basic 82.11% 83.36% 14.55% -89.43% -278.71%
Normalized Basic EPS 82.60% 83.93% -3.23% -111.76% -293.48%
EPS Diluted 82.11% 83.36% 14.55% -89.43% -278.71%
Normalized Diluted EPS 82.60% 83.93% -3.23% -111.76% -293.48%
Average Basic Shares Outstanding 161.29% 114.43% 70.77% 32.57% 30.22%
Average Diluted Shares Outstanding 161.29% 114.43% 70.77% 32.57% 30.22%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings